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Abstract: NanoMIPs that are prepared by solid phase synthesis have proven to be very versatile, 
but to date only limited attention has been paid to their use in solid phase extraction. Thus, since 
nanoMIPs show close similarities, in terms of binding behavior, to antibodies, it seems relevant to 
verify if it is possible to use them as mimics of the natural antibodies that are used in immunoex-
traction methods. As a proof-of-concept, we considered prepared nanoMIPs against fluoroquino-
lone ciprofloxacin. Several nanoMIPs were prepared in water with polymerization mixtures of dif-
ferent compositions. The polymer with the highest affinity towards ciprofloxacin was then grafted 
onto a solid support and used to set up a solid phase extraction–HPLC method with fluorescence 
detection, for the determination of fluoroquinolones in human urine. The method resulted in suc-
cessful selection for the fluoroquinolone antibiotics, such that the nanoMIPs were suitable for direct 
extraction of the antibiotics from the urine samples at the µg mL−1 level. They required no prelimi-
nary treatment, except for a 1 + 9 (v/v) dilution with a buffer of pH 4.5 and they had good analyte 
recovery rates; up to 85% with precision in the range of 3 to 4.5%, without interference from the 
matrix. These experimental results demonstrate, for the first time, the feasibility of the use of nano-
MIPs to develop solid phase extraction methods. 
Keywords: molecularly imprinted polymer; nanoMIP; solid phase synthesis; MISPE; solid phase 
extraction; fluoroquinolone; ciprofloxacin; urine 
 
1. Introduction 
Molecularly imprinted polymers (MIPs) find in the so-called “molecularly imprinted 
solid phase extraction” (MISPE) technique one of their most popular applications, con-
sisting of selectively extracting target analytes in the presence of interfering substances 
and complex matrices. Whether in the form of cartridges [1], monoliths [2], magnetic par-
ticles [3], or nanofibers [4], the application of MIPs to extraction problems is certainly 
competitive due to their resistance to chemical and biological degradation, the versatility 
of their applications and the operative costs (if compared to similar methods based on 
natural receptors such as immunoaffinity extraction) [5,6]. 
Despite these advantageous characteristics, the MISPE technique shows several 
drawbacks which limit its wider applicability. First of all, the preparation of the imprinted 
material requires the introduction into the polymerization mixture of a fair amount of the 
target molecule that must act as a template [7]. Thus, the preparation of an adequate quan-
tity of the polymer requires a large quantity of the template, which cannot always be re-
covered and recycled. In the case of analytes that are difficult to find, expensive or unsta-
ble, or those that represent a hazard to health or safety, this is a practical obstacle that 
cannot be easily overcome. Furthermore, the complete removal of the template from the 
imprinted polymer is frequently rather difficult [8,9] and the unextracted residues can 
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slowly leach out in the so-called “bleeding effect”, contaminating the samples in the solid 
phase extraction process and irreparably compromising the results of the analysis. 
To overcome these drawbacks, the “mimic template” technique has been introduced, 
where a putative molecule that is structurally similar to the target molecule is able to raise 
imprinted binding sites but does not interfere with the subsequent analytical technique. 
This approach avoids the bleeding effect, but still requires the availability of large quan-
tities of the mimic template, which frequently must be prepared by ad hoc synthesis [10]. 
An innovative approach to solving all of these issues is presented by the solid phase 
synthesis of nanoMIPs [11,12]. In this process, illustrated in Scheme 1, the polymerization 
process takes place in the interstitial space between packed glass beads that are covalently 
grafted with template molecules. The growth of cross-linked polymeric chains takes place 
in proximity to the glass beads’ surfaces, resulting in the imprinting of the nascent nano-
particles by the grafted template molecules. At the end of the polymerization process, any 
residual monomers, polymerization by-products and low-affinity polymers are washed 
away, whilst the high-affinity nanoMIPs are recovered by washing with a solution capable 
of breaking the non-covalent molecular interactions between the imprinted nanoparticles 
and the grafted template molecules. This solid phase synthesis technique addresses many 
of the drawbacks of traditional solution-synthesis techniques. In fact, because the template 
molecules are covalently grafted onto the glass beads, no residual template molecules are 
present in the nanoMIPs, avoiding the bleeding effect entirely. Moreover, as the function-
alized glass beads require a small amount of the template and can be cleaned and reused 
many times, this approach allows the use of expensive templates. Additionally, in the case 
of toxic or harmful substances, the confinement of the reaction to the glass beads’ surfaces 
eliminates any health risks during the manipulation of the solid phase [13]. 
 
Scheme 1. Preparation of nanoMIPs by solid phase synthesis method. 
Solid phase synthesis has proved to be very versatile and nanoMIPs that are able to 
target small molecules [14,15], macrocyclic antibiotics [16,17], toxins [18,19], and peptides 
[20,21] have been described, and used, for the development of sensors and biomimetic 
assays. However, to date only limited attention has been paid to the use of nanoMIPs in 
solid phase extraction [14]. Therefore, since nanoMIPs show close similarities, in terms of 
binding behavior, to natural antibodies, it seems relevant to verify if it is possible to use 
them as substitutes for natural antibodies in immunoextraction methods. 
As a proof-of-concept, we considered prepared nanoMIPs against ciprofloxacin, a 
fluoroquinolone of relevant interest as an analytical target in MISPE [22–24] on which we 
have recently published the characterization of the binding properties [25,26]. Several na-
noMIPs were prepared with polymerization mixtures of different compositions and the 
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polymer with the highest affinity towards ciprofloxacin was used to set up a method for 
the extraction of the target analyte from human urine. 
2. Materials and Methods 
2.1. Materials 
The template molecule, ciprofloxacin hemisuccinamide (CIP-HS), was synthesized 
according to a modified version of the procedure given by Noël et al. [27]. Glass beads 
(Spheriglass-2429, 70–100 μm average particle size, Potters, UK) were aminated and 
grafted with the template as previously described [26]. The acrylic acid (AA), chlortetra-
cycline (CTX), ciprofloxacin (CIP), danofloxacin (DAN), enrofloxacin (ENR), N-isopropy-
lacrylamide (NIPAm), levofloxacin (LEV), lomefloxacin (LOM), N,N′-methylene-bis-
acrylamide (BIS), morpholinoethansulfonic acid (sodium salt, MES), moxifloxacin (MOX), 
norfloxacin (NOR), sarafloxacin (SAR), N-tert-butylacrylamide (TBAm), ammonium per-
sulphate (APS) and N,N,N′,N′-tetramethylethylenediamine (TEMED) that were used in 
this study were purchased from Merck (Milan, Italy). The solvents and all other chemicals 
were also purchased from Merck (Milan, Italy). All of the solvents were of HPLC grade, 
whereas all of the chemicals were of analytical grade. The water used was ultra-purified 
in a PURELAB Prima System from Elga (Marlow, UK). The fluoroquinolone stock solu-
tions were prepared by dissolving 25 mg of the substance in 25 mL of water/methanol 1 + 
1 (v/v), these solutions were then stored in the dark at −20 °C. 
Synthetic urine was prepared as previously reported [28], stored at 4 °C and dis-
carded no later than a week after its preparation. 
2.2. Synthesis of NanoMIPs 
The polymerization mixtures were prepared by modifying the general protocol re-
ported in the literature [13] and adjusting the dilution of the monomers in order to avoid 
the formation of unwanted lumps of polymer. All of the mixtures (the molar compositions 
of which are reported in Table S1, Supplementary Materials) were made in 25 mL of ul-
trapure water by mixing BIS, AA, NIPAm and TBAm (each of which was dissolved in 0.5 
mL of ethanol). Then, 5 mL of each of the mixtures was added to 50 mL capacity polypro-
pylene SPE cartridges containing 2.5 g of functionalized glass beads. The cartridges were 
purged with nitrogen for 5 min, 3 µL of TEMED and 100 µL of a 30 mg mL−1 aqueous 
solution of APS were added, and then polymerization was carried out at room tempera-
ture for 1 h in a roller-equipped incubator. The supernatant was drained by vacuum aspi-
ration, the dry cartridges were cooled to 4 °C and the polymerization by-products and 
low-affinity nanoMIPs were washed with 10 × 2 mL of ice-cold water. The high-affinity 
nanoMIPs were collected by eluting the cartridges with 5 × 2 mL of hot water. The eluates 
were lyophilized, weighed and stored at 4 °C. 
The nanoMIPs were grafted onto aminated glass beads in accordance with the pro-
tocol that has been previously reported [26]. 
2.3. HPLC Method 
A reverse-phase HPLC analysis was used for fluoroquinolone determination. The 
HPLC apparatus (Merck-Hitachi, Milan, Italy) that was utilized was a LaChrom Elite sys-
tem, composed of a programmable binary pump (L-2130), an auto-sampler (L-2200) and 
a fluorescence detector (L-7485). The LaChrom Elite system was provided with EZChrom 
Elite software for instrumental programming, data acquisition and data processing. The 
column used was a 100 mm × 4.6 mm C-18 Onyx (Phenomenex, Milan, Italy). The mobile 
phases used were water/acetonitrile 88 + 12, acetic acid 1% (v/v) for fluoroquinolones, a 50 
mmol L−1 acetate buffer and pH 8.1/methanol 40 + 60 (v/v) for chlortetracycline. Elution 
was performed in isocratic conditions at a flow rate of 0.7 mL min−1. The sample volume 
that was injected was 5 μL and the fluorescence wavelengths were: CIP, DAN, ENR, LOM, 
NAR, SAR: λex = 280/λem = 440 nm; LEV: λex = 278/λem = 540 nm; MOX: λex = 294/λem = 503 nm; 
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and CTX: λex = 380/λem = 532 nm. The analyte solutions between 5 and 100 ng mL−1 in con-
centration were analyzed in triplicate and the mean peak areas were plotted against each 
concentration. The calibration plot was drawn by using a weighted linear regression 
(weight = 1/conc). 
2.4. Determination of Binding Properties 
To measure the equilibrium binding isotherms, unbound fractions of fluoroquin-
olones were measured by reverse-phase HPLC analysis with fluorescence detection, in 
accordance with the previous literature [25]. Each experimental data point was assessed 
as the average of three repeated measures and binding parameters were calculated in ac-
cordance with the Langmuir binding isotherm by nonlinear least squares fitting. 
2.5. Preparation of MISPE Cartridges 
Adequate amounts of glass beads grafted with nanoMIPs (1 g) were suspended in 
water and packed into 5 mL capacity, empty polypropylene SPE cartridges that were pro-
vided with frits to secure the packing and outlet stopcocks. The columns were connected 
to a vacuum manifold and washed extensively with water, then dried under a vacuum. 
Immediately before any use, the cartridges were activated with 500 µL of MES buffer 50 
mmol L−1, pH 4.5. When necessary, the columns were cleaned and regenerated by washing 
with 500 µL mL of water/acetic acid 9 + 1 v/v and 3 × 500 µL of water. 
2.6. Optimization of the MISPE Method 
In order to optimize the procedure of fluoroquinolone extraction, different protocols 
were applied during the loading and washing steps. In the subsequent experiments, each 
extraction was repeated three times and the amount of analyte recovery was evaluated as 
the average of the single values that were measured. 
To investigate the effects of the different loading solutions, ciprofloxacin (200 ng 
mL−1) in synthetic urine was diluted 1 + 9 v/v with 50 mmol L−1 MES (pH 4.5–5.5) or phos-
phate buffers (pH 6.5–8.5), and then 250 µL of diluted solution was loaded into the car-
tridge. After the sample loading, the cartridge was washed with 250 µL of methanol/acetic 
acid 9 + 1 v/v. 
To investigate the effects of the different washing solutions, ciprofloxacin (200 ng 
mL−1) in synthetic urine was diluted 1 + 9 v/v with 50 mmol L−1 MES buffer, pH 4.5, then 
250 µL of diluted solution was loaded into the cartridge. After the sample loading, air was 
passed through the cartridge for 10 min in order to remove all of the residual traces of the 
solution. Then, the cartridge was washed with 250 µL of 50 mmol L−1 MES buffer, pH 4.5, 
ultrapure water, methanol, acetonitrile, acetone, tetrahydrofuran or ethyl acetate. Air was 
passed through the cartridge for 10 min to remove all of the residual traces of the washing 
solution and the retained ciprofloxacin was eluted with 250 µL of methanol/acetic acid 9 
+ 1 v/v. 
To investigate the effects of the different loading volumes, ciprofloxacin (200 ng mL−1) 
in synthetic urine was diluted 1 + 9 v/v with 50 mmol L−1 MES buffer, pH 4.5 and 0.10, 0.25, 
0.50, 1.00, 2.00 or 5.00 mL of diluted solution was loaded into the cartridge. Then, air was 
passed through the cartridge for 10 min in order to remove all of the residual traces of the 
loading solution and the retained ciprofloxacin was eluted with 250 µL of methanol/acetic 
acid 9 + 1 v/v. 
2.7. MISPE Selectivity 
In order to investigate the selectivity of the optimized extraction protocol in the load-
ing solution, ciprofloxacin was substituted with 7 other fluoroquinolones (danofloxacin, 
enrofloxacin, levofloxacin, lomefloxacin, moxifloxacin, norfloxacin and sarafloxacin), and 
chlortetracycline, which was chosen as an unrelated substance. For each of these ligands, 
a standard solution of 200 ng mL−1 in synthetic urine was diluted 1 + 9 v/v with 50 mmol 
Separations 2021, 8, 226 5 of 13 
 
 
L−1 MES buffer, pH 4.5 and then 250 µL of this diluted solution was loaded into the car-
tridge. Then, air was passed through the cartridge for 10 min in order to remove all of the 
residual traces of the solution. The retained ligands were eluted with 250 µL of metha-
nol/acetic acid 9 + 1 v/v. 
2.8. MISPE of Real Samples 
Blank urine samples collected from four individuals were mixed and then filtered 
through a 0.22 µm polypropylene membrane. The resulting 10 mL samples were spiked 
with known amounts of ciprofloxacin (ranging from 2 to 20 µg), or a mixture of ciproflox-
acin, danofloxacin and norfloxacin (20 µg each), and then immediately extracted with the 
optimized protocol reported in Section 2.7. To evaluate the reproducibility of the MISPE 
protocol, each extraction was repeated five times and the rate of analyte recovery was 
evaluated as the average of the single values that were measured. 
3. Results 
3.1. Optimization of the Polymerization Mixture 
The polymerization mixture that has been previously used [26] to prepare nanoMIPs 
with molecular ciprofloxacin recognition properties was composed of a cross-linking 
agent (N,N′-methylene-bis-acrylamide) and two functional monomers, which have the 
task of interacting with the template through either hydrogen bonds/ion pairs (acrylic 
acid) or hydrophobic interactions (N-tert-butylacrylamide). These monomers constitute 
70% molar of the mixture, the remaining 30% of which consists of N-isopropylacrylamide, 
a thermoresponsive monomer that is useful for the selective detachment of nanoMIPs 
from the solid phase at the end of the synthesis process. However, since we were not sure 
that this mixture was optimal for obtaining nanoMIPs that are characterized by a high 
affinity constant towards ciprofloxacin, we chose to utilize a two-factor central composite 
(d = 2, n = 9) experimental design by varying the relative quantity of the cross-linker (1–5 
mol%) and the functional monomers (acrylic acid, 10–50 mol%) in the polymerization mix-
tures, keeping unchanged the amount of thermoresponsive monomer. 
The binding affinities for ciprofloxacin calculated from Langmuirian binding models 
(the results of which are reported in Table S2, Supplementary Materials) were fitted 
against the molar percentages of AA and tBAM by using a six-parameter polynomial 
model. The response surface, reported in Figure 1, fits quite well with the experimental 
design points used in the design, with r2 = 0.921 and fit standard error = 0.607 (see Table 
S3, Supplementary Materials). Less complex five- or four-parameter designs that were 
lacking in interaction or quadratic parameters were discarded because they produced re-
sponse surfaces with lower correlation coefficients (r2 < 0.8) and higher fit standard errors 
(>1–2), As the polynomial model that was used provides an interaction term between the 
independent variables (parameter a5 in Table S3), the resulting surface shows an obvious 
saddle shape, with two distinct regions where the binding affinities are higher and an 
intermediate region with a saddle-centered maximum where the binding affinities are 
lowest. It should be noted that the formulation of the polymerization mixture previously 
reported in literature [26] corresponds to a response surface region characterized by high 
binding constants. For these reasons, several polymers with very different molar compo-
sition were potentially suitable to set up a MISPE protocol with, among which we have 
chosen the formulation P6, which corresponds to nanoMIPs with high affinity (3.00 ± 0.75 
× 106 M−1) and binding site concentration (18.8 ± 2.9 nmol g−1). 




Figure 1. Responding surface of the two-factor central composite design. Red dots: experimental 
points. 
3.2. Optimization of the MISPE Protocol 
In order to optimize the procedure of fluoroquinolone extraction, we initially focused 
our attention on the composition of the loading and washing solutions. Synthetic urine 
containing 200 ng mL−1 of ciprofloxacin was diluted 1 + 9 with buffers of different pH 
levels. As reported in Figure 2, there is a clear effect of the buffer’s pH on the retention of 
ciprofloxacin, as the acidic buffer shows a limited loss of analytes while the neutral and 
basic pH buffers do not quantitatively retain them. This result confirms the results re-
ported in literature, where ciprofloxacin-binding nanoMIPs show binding constants de-
creasing when pH increases [26]. 
 
Figure 2. Effect of pH on loading of 1 mL of synthetic urine containing 200 ng mL−1 of ciprofloxacin, 
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Once optimal loading conditions were defined, we evaluated the effect of the wash-
ing solutions; considering 1 mL of water, an MES buffer at pH 4.5 and organic solvents of 
decreasing polarity (methanol, acetonitrile, acetone, tetrahydrofuran and ethyl acetate). 
As reported in Figure 3, none of these solutions, with the exception of the less-polar ethyl 
acetate, is capable of quantitatively retaining ciprofloxacin. It should be noted that the 
loading buffer is also unable to fully retain the analyte, even if the loss is significantly less 
(~25%) than that of all of the other solutions. As a consequence of this result and taking 
into account that, by eluting the cartridges loaded with real urine samples with ethyl ace-
tate, the corresponding chromatogram does not show any peak whatsoever, it was there-
fore decided to omit the washing step, limiting the process to drying the cartridges care-
fully after loading the sample. 
 
Figure 3. Effect of 1 mL of washing solutions on retention of ciprofloxacin after loading of 1 mL of 
synthetic urine containing 200 ng mL−1 of ciprofloxacin, diluted 9 + 1 v/v with 50 mmol L−1 MES 
buffer, pH 4.5. 
The effect of increasing the loading volumes was evaluated considering samples of 
synthetic urine spiked with ciprofloxacin at a fixed concentration of 200 ng mL−1 and di-
luted 1 + 9 v/v with 50 mmol L−1 of MES buffer. The results, reported in Figure 4, show that 
when the loading volumes are larger than 0.25 mL, the recovery of the analyte drops 
sharply, becoming very small when 5 mL of the sample is loaded. This is unexpected, as 
the nanoMIP P6 that was used to prepare the MISPE cartridges shows a binding site con-
centration of 18.8 ± 2.9 nmol g−1. This is a static binding capacity of ~6 µg/cartridge of 
ciprofloxacin, corresponding to 60 times greater than the amount present in 5 mL of the 
sample. The cause of this poor loading capacity is unclear, but, in any case, a loading vol-



























Figure 4. Effect of sample loading volumes on retention of ciprofloxacin, 200 ng mL−1 in synthetic 
urine, diluted 9 + 1 v/v with 50 mmol L−1 MES buffer, pH 4.5. 
3.3. MISPE Selectivity 
The selectivity of the optimized MISPE protocol was investigated by extracting sev-
eral analogues that are related to different generations of antibiotics [29], the molecular 
structures of which are reported in Scheme 2. They are different from ciprofloxacin by 
substituents but they share the common fluoroquinolone nucleus. 
 
Scheme 2. Template, fluoroquinolones with similar molecular structure and chlortetracycline. In 
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The results, reported in Figure 5, show that the imprinted cartridge is able to retain 
all of the examined fluoroquinolones with recovery rates greater than 80%, while chlor-
tetracycline (an antibiotic substance with a molecular structure completely different from 
that of fluoroquinolones) is poorly retained. The group selectivity shown by the nanoMIPs 
can be explained by considering that the positions on the rigid molecular structure of the 
fluoroquinolone, which presumably are most responsible for the interaction with the 
binding site, correspond to the positions C3 (carboxyl) and C4 (quinone); these are far 
from the positions N1 and C7 that determine structural differences. It follows that the 
significant molecular recognition of all fluoroquinolones is essentially determined by the 
presence of some ubiquitous structures on this class of molecules. These ubiquitous struc-
tures are the condensed ring systems that give shape and size to the binding site and the 
presence of the carboxyl-quinone system in positions C3-C4, which guarantees the same 
non-covalent interaction mechanism for all molecules. Moreover, it is clear that the basic 
shape of the ligands is equally important. Chlortetracycline, which possesses a pair of 
substituents in the C1-C2 positions (similar to the carboxyl-quinone system) but exhibits 
a radically different condensed ring system, is poorly recognized by nanoMIPs. 
 
Figure 5. Selectivity after loading of 1 mL of synthetic urine containing 200 ng mL−1 of analyte, di-
luted 9 + 1 v/v with 50 mmol L−1 MES buffer, pH 4.5. 
3.4. MISPE of Real Samples 
In order to evaluate the ability of the MISPE cartridges to extract from real samples 
of human urine, blanks were spiked with known amounts of ciprofloxacin or a mixture of 
three different fluoroquinolones (ciprofloxacin, danofloxacin, and norfloxacin). 
The recovery of ciprofloxacin was determined by comparing the HPLC detector re-
sponses of five different urine samples. The recovery rates, reported in Table 1, were de-
termined at five concentration levels of ciprofloxacin (between 0.2 to 2 µg mL−1), resulting 
in levels between about 82% and 85% with a relative standard deviation <5%. Moreover, 
pairwise t-tests performed to compare the recovery rates obtained at different ciprofloxa-
cin concentrations showed no statistical differences between the groups, with t-values (n 
= 5, α = 0.05) between 0.290 and 0.938. These results show that the extraction protocol 
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Table 1. Recovery of ciprofloxacin in human urine after dilution 9 + 1 v/v with 50 mmol L−1 MES 
buffer, pH 4.5 and MISPE. Values are the mean ± 1σ of 5 samples. 
Ciprofloxacin, µg mL−1 Recovery, % 
0.2 84.8 ± 4.4 
0.5 82.7 ± 4.5 
1.0 85.4 ± 4.5 
1.5 82.9 ± 3.6 
2.0 85.0 ± 3.1 
1 t-values for pairwise comparison: 0.432 (0.2 vs. 0.5 µg mL−1), 0.821 (0.2 vs. 1.0 µg mL−1), 0.477 (0.2 
vs. 1.5 µg mL−1), 0.910 (0.2 vs. 2.0 µg mL−1), 0.316 (0.5 vs. 1.0 µg mL−1), 0.938 (0.5 vs. 1.5 µg mL−1), 
0.290 (0.5 vs. 2.0 µg mL−1), 0.352 (1.0 vs. 1.5 µg mL−1), 0.880 (1.0 vs. 2.0 µg mL−1), 0.334 (1.5 vs. 2.0 
µg mL−1). 
Satisfactory sample clean-up was achieved; this can be seen in the example reported 
in Figure 6, where the chromatograms of before and after the MISPE of the urine spiked 
with the fluoroquinolone mixture at a concentration level of 2 µg mL−1 are reported. When 
comparing the chromatograms, it can be seen that fluoroquinolones can be detected with 
some difficulty when a sample of urine is separated directly by reverse phase-HPLC with-
out preliminary MISPE, while the same sample that was analyzed after MISPE shows a 
cleaner chromatographic trace, where the peaks corresponding to fluoroquinolones can 
be more easily detected and, as a consequence, quantified. 
 
Figure 6. HPLC chromatogram of human urine spiked with ciprofloxacin, danofloxacin, and nor-
floxacin at final concentration of 2 µg mL−1 and diluted 9 + 1 v/v with 50 mmol L−1 MES buffer, pH 
4.5. Blue line: sample injected without MISPE; green line: not retained eluate from MISPE cartridge; 
red line: eluate from MISPE cartridge. 
4. Discussion 
In this work, we demonstrate that it is possible to use nanoMIPs prepared by solid 
phase synthesis to develop a MISPE technique that is suitable for real matrices. This result 
was not taken for granted from the start; in fact, unlike materials prepared through more 
traditional molecular imprinting techniques, solid phase synthesis allows the preparation 
of nanopolymers only in very small quantities, at the level of mg per synthesis cycle. Fur-
thermore, the typical dimensions of nanoMIPs obviously do not make their direct use as 
packing materials for SPE cartridges possible. We, therefore, thought of supporting nano-
MIPs on glass microspheres, based on an experimental approach that we have previously 
used to successfully measure the binding isotherms of this type of nanomaterials [25,26]. 
We also considered it feasible to use very limited amounts of the nanoMIPs by designing 
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their use in this study to align with the use of natural antibodies in the preparation of 
cartridges for immunoaffinity studies. In fact, even in this case, the typical quantity of 
antibodies that are covalently bound to the supports is very small. Nonetheless, this small 
amount does not affect the extraction efficiency of the method [30]. However, it should be 
noted that the attempt to preconcentrate the samples to further increase the method’s sen-
sitivity was not effective, as the ability of MISPE cartridges to retain the analytes with 
loading volumes greater than 0.25 mL involves a significant drop in the recovery rate. 
Since the static binding capacity of the MISPE cartridges used is much greater than the 
amount of ciprofloxacin that is actually loaded into them, even in the presence of large 
sample volumes, it is clear that further studies will be necessary to clarify the origin of this 
behavior and to try to find a possible remedy. 
In conclusion, the experimental results reported here show a MISPE/HPLC method 
allowing the direct extraction of fluoroquinolones from buffered urine samples at the µg 
mL−1 level, with good recovery rates and precision, without interference from the matrix. 
We believe that these results are, although limited to a small number of analytes in a single 
real matrix, a good proof-of-concept for the use of nanoMIPs in MISPE methods. 
Supplementary Materials: The following are available online at www.mdpi.com/arti-
cle/10.3390/separations8110226/s1, Table S1: molar composition of the prepolymerization mixtures 
used in the experimental design and resulting binding affinities of the corresponding nanoMIPs. 
Table S2: nonlinear fitting of Langmuirian binding models for ciprofloxacin-imprinted nanoMIPs. 
Table S3: nonlinear fitting of 6-parameter polynomial model for the two-factor central composite (d 
= 2, n = 9) experimental design. 
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draft preparation, M.C.; writing—review and editing, C.B. All authors have read and agreed to the 
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